About 1 Mg Anastrozole Tablets IP
Grab Yours: ANASTROZOLE TABLETS IP 1 mg exemplifies sterling potency in oncology treatment, tailored for the heroic battle against hormone receptor-positive breast cancer in postmenopausal women. Pick Yours from DRUGMAN SYRUPS-an IP-certified, prescription-only formulation ensuring purity and efficacy. Personalise your therapeutic regimen with a highly selective aromatase inhibitor, expertly packed in Alu-Alu blister strips (10 tablets each). Odorless, white to off-white, film-coated round tablets deliver consistent anastrozole strength (1 mg/tablet). Minimum order: 15,000 packs; shelf life: 24 months. Suitable for distributor, supplier, trader, and export across India.
Potent Features & Versatile Applications
ANASTROZOLE TABLETS IP 1 mg are highly selective aromatase inhibitors, making them effective for hormone-dependent breast cancer therapy. Use is specifically tailored for postmenopausal women with oral administration, ensuring clinical ease. Applications expand from hospital oncology departments to specialty clinics, ensuring patients benefit from potent estrogen reduction. The unique composition and superior packaging promise consistent efficacy and stability during the product's 24-month shelf life.
Supply, Sample Policy & Export Readiness
Dispatched efficiently in secure Alu-Alu blister packs, ANASTROZOLE TABLETS IP 1 mg cater to bulk supply with a minimum order of 15,000 packs. Sample policies accommodate genuine distributor requests for market development. Packaging ensures product integrity during transportation, supporting export markets nationwide. The robust supply ability means pharmaceutical traders and exporters in India can rely on fast, compliant deliveries, protected from light and moisture for optimal shelf life.
FAQ's of 1 Mg Anastrozole Tablets IP:
Q: How should 1 mg Anastrozole Tablets IP be stored for maximum efficacy?
A: Store the tablets below 30C in a dry place, protected from light, to preserve their potency and ensure the full 24-month shelf life.
Q: What is the primary usage of ANASTROZOLE TABLETS IP 1 mg?
A: These tablets are primarily indicated for hormone receptor-positive breast cancer treatment in postmenopausal women, serving as a highly selective aromatase inhibitor.
Q: When is ANASTROZOLE TABLETS IP contraindicated?
A: Use is contraindicated during pregnancy, lactation, and in individuals hypersensitive to anastrozole.
Q: Where can ANASTROZOLE TABLETS IP 1 mg be sourced or exported?
A: Distributed, exported, and traded across India through DRUGMAN SYRUPS with robust packaging and compliance to IP-Indian Pharmacopeia standards.
Q: What process ensures the quality of ANASTROZOLE TABLETS IP packaging?
A: High-grade Alu-Alu blister packs shield the tablets from moisture, contamination, and physical damage during transportation and storage.
Q: How does Anastrozole exert its therapeutic effect?
A: Anastrozole inhibits the aromatase enzyme, leading to a potent reduction of estrogen production-a critical mechanism in treating hormone-dependent breast cancer.